Patents by Inventor Yixin He

Yixin He has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11939578
    Abstract: The present invention relates to the field of biomedicine, particularly to double-stranded RNA molecules targeting CKIP-1 and uses thereof, particularly to use of the double-stranded RNA molecules for the treatment of inflammatory diseases such as arthritis, particularly rheumatoid arthritis.
    Type: Grant
    Filed: September 14, 2021
    Date of Patent: March 26, 2024
    Assignee: BEIJING TIDE PHARMACEUTICAL CO., LTD.
    Inventors: Yanping Zhao, Hongjun Wang, Yuanyuan Jiang, Weiting Zhong, Jianmei Pang, Gong Li, Xiang Li, Yixin He, Liying Zhou, Yanan Liu
  • Publication number: 20220064645
    Abstract: The present invention relates to the field of biomedicine, particularly to double-stranded RNA molecules targeting CKIP-1 and uses thereof, particularly to use of the double-stranded RNA molecules for the treatment of inflammatory diseases such as arthritis, particularly rheumatoid arthritis.
    Type: Application
    Filed: September 14, 2021
    Publication date: March 3, 2022
    Inventors: Yanping ZHAO, Hongjun WANG, Yuanyuan JIANG, Weiting ZHONG, Jianmei PANG, Gong LI, Xiang LI, Yixin HE, Liying ZHOU, Yanan LIU
  • Patent number: 11155819
    Abstract: The present invention relates to the field of biomedicine, particularly to double-stranded RNA molecules targeting CKIP-1 and uses thereof, particularly to use of the double-stranded RNA molecules for the treatment of inflammatory diseases such as arthritis, particularly rheumatoid arthritis.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: October 26, 2021
    Assignee: BEIJING TIDE PHARMACEUTICAL CO., LTD.
    Inventors: Yanping Zhao, Hongjun Wang, Yuanyuan Jiang, Weiting Zhong, Jianmei Pang, Gong Li, Xiang Li, Yixin He, Liying Zhou, Yanan Liu
  • Publication number: 20210198672
    Abstract: The invention relates to the field of biomedicine. Specifically, the present invention relates to aptamers against sclerostin and uses thereof, especially uses in the treatment of sclerostin-related diseases such as osteoporosis.
    Type: Application
    Filed: February 11, 2019
    Publication date: July 1, 2021
    Applicant: APTACURE THERAPEUTICS LIMITED
    Inventors: Ge Zhang, Yuanyuan Yu, Shuaijian Ni, Yixin He
  • Publication number: 20200231967
    Abstract: The present invention relates to the field of biomedicine, particularly to double-stranded RNA molecules targeting CKIP-1 and uses thereof, particularly to use of the double-stranded RNA molecules for the treatment of inflammatory diseases such as arthritis, particularly rheumatoid arthritis.
    Type: Application
    Filed: September 7, 2018
    Publication date: July 23, 2020
    Inventors: Yanping ZHAO, Hongjun WANG, Yuanyuan JIANG, Weiting ZHONG, Jianmei PANG, Gong LI, Xiang LI, Yixin HE, Liying ZHOU, Yanan LIU
  • Publication number: 20130013597
    Abstract: The present disclosure introduces a method, an apparatus, and a system of processing repetitive data. In an example embodiment, the data structure of the comparison data to be compared is processed as having a same data structure of the data in the repetition database. The repetition database is formed by an internal memory mapping after processing data in a database according to a preset data structure. The processed comparison data is compared with data in the repetition database to determine whether the comparison data is repetitive data. After it is determined that the comparison data is not repetitive data, the comparison data is written into the database. The techniques described herein improve the efficiency of the servers for eliminating repetitive data and save the server resources.
    Type: Application
    Filed: June 14, 2012
    Publication date: January 10, 2013
    Applicant: ALIBABA GROUP HOLDING LIMITED
    Inventors: Yixin He, Ruihai Ye, Xieyao Wu, Wenbo Zhang